Prostate-specific antigen (PSA) measurements' association with metastasis and mortality in patients with nmCRPC (non-metastatic castration resistant prostate cancer).

被引：1
|
作者：
Li, Sophia
Ding, Zhijie
Lin, Jennifer H.
Behl, Ajay S.
Pericone, Chris
Deshmukh, Siddhant
Macomson, Brian
Shore, Neal D.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Mu Sigma Business Solut Pvt Ltd, Bengaluru, India
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17058
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancer
    Kanao, Kent
    Ito, Toshiki
    Takahara, Kiyoshi
    Ando, Ryosuke
    Yasui, Takahiro
    Shiroki, Ryoichi
    Miyake, Hideaki
    Sumitomo, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 1043 - 1048
  • [22] Prostate-Specific Antigen Flare Induced by (223)Ra therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Castello, A.
    Macapinlac, H. A.
    Santos, E. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S211 - S211
  • [23] THE ASSOCIATION OF COUNTY-LEVEL PROSTATE-SPECIFIC ANTIGEN SCREENING WITH METASTATIC PROSTATE CANCER AND PROSTATE CANCER MORTALITY
    Stone, Benjamin J.
    Labban, Muhieddine
    Beatrici, Edoardo
    Filipas, Dejan K.
    D'Amico, Anthony V.
    Lipsitz, Stuart R.
    Choueiri, Toni K.
    Kibel, Adam S.
    Cole, Alexander P.
    Iyer, Hari S.
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2024, 211 (05): : E439 - E440
  • [24] THE ASSOCIATION OF COUNTY-LEVEL PROSTATE-SPECIFIC ANTIGEN SCREENING WITH METASTATIC PROSTATE CANCER AND PROSTATE CANCER MORTALITY
    Stone, Benjamin V.
    Labban, Muhieddine
    Beatrici, Edoardo
    Filipas, Dejan K.
    Lipsitz, Stuart R.
    Kibel, Adam S.
    Cole, Alexander P.
    Trinh Quoc-Dien
    D'Amico, Anthony V.
    Choueiri, Toni K.
    Iyer, Hari S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S79 - S80
  • [25] The association of county-level prostate-specific antigen screening with metastatic prostate cancer and prostate cancer mortality
    Stelzl, D.
    Stone, B. V.
    Labban, M.
    Beatrici, E.
    Filipas, D. K.
    D'Amico, A. V.
    Lipsitz, S. R.
    Choueiri, T. K.
    Kibel, A. S.
    Cole, A. P.
    Iyer, H. S.
    Trinh, Q-D.
    EUROPEAN UROLOGY, 2024, 85 : S1599 - S1600
  • [26] The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality
    V. Stone, Benjamin
    Labban, Muhieddine
    Beatrici, Edoardo
    Filipas, Dejan K.
    D'Amico, Anthony, V
    Lipsitz, Stuart R.
    Choueiri, Toni K.
    Kibel, Adam S.
    Cole, Alexander P.
    Iyer, Hari S.
    Trinh, Quoc-Dien
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 563 - 569
  • [27] Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer
    Howard, Lauren E.
    Moreira, Daniel M.
    De Hoedt, Amanda
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Terris, Martha K.
    Freedland, Stephen J.
    BJU INTERNATIONAL, 2017, 120 (5B) : E80 - E86
  • [28] Physician benefit-risk preferences for non-metastatic castration-resistant prostate cancer treatment (nmCRPC).
    Srinivas, Sandy
    Mohamed, Ateesha F.
    Appukkuttan, Sreevalsa
    Botteman, Marc
    Ng, Xinyi
    Joshi, Namita
    Horodniceanu, Erica
    Waldeck, Reg
    Simmons, Stacey J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] CHARACTERISTICS AND TREATMENT PATTERNS FOR NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS IN GERMANY, FRANCE, AND UNITED KINGDOM (UK)
    Shah, R.
    Ikeme, S.
    Botteman, M.
    Waldeck, R.
    VALUE IN HEALTH, 2019, 22 : S85 - S85
  • [30] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
12345